Eton Pharmaceuticals Inc - ETON Net Assets per Single Share

Graphic logo of Eton Pharma (ETON)

Eton Pharmaceuticals (ETON) minimizes environmental impact through digitalization and adherence to fundamental ecological standards. Business revenues are based on the sale of vital treatments for individuals with neurological and endocrine pathologies via insurance systems, with the current figure standing at 1.65. Price action confirms the creation of an irreplaceable therapeutic circuit with extremely high switching costs for patients with rare diseases.

Eton Pharma - ETON Net Assets per Share (period 07/04/2022 - 10/28/2026)

Summary analytical data breakdowns for etonpharma.com (ETON)

- price and consensus price forecast:
Price Chart Eton Pharma|ETON - Average Forecast Price
- market capitalization data:
Market Value Eton Pharmaceuticals, Inc.|ETON - Business Value
- book capitalization data:
Net Assets per Single Share Eton Pharmaceuticals|ETON - Book Valuation of Business|Market Value to Book Value Ratio etonpharma.com|ETON - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital Eton Pharmaceuticals|ETON - Long-Term Liabilities to Capital|Short-Term Debt to Capital Eton Pharmaceuticals, Inc.|ETON - Company Total Debt|Debts to Book Capitalization Eton Pharmaceuticals, Inc.|ETON - Long-Term Debt Volume|Company Short-Term Debts Eton Pharmaceuticals
Analysis of all company metrics:Eton Pharma ETON
Finished products of etonpharma.com

Book value separates real capital from market speculation by measuring the share of net assets per security after deducting all liabilities. The bet by Eton Pharmaceuticals (ETON) on high-efficiency FDA experts and a flexible option system confirms the business's intellectual value, which is reflected in the book value per share as an indicator of the company's fundamental stability.

Competitors of Eton Pharmaceuticals (ETON)

VRTX (Vertex Pharmaceuticals Inc.) - Net Assets per Single Share|ALNY: Net Asset Value per Share|Net Assets per Single Share Insmed Incorporated|UTHR (unither.com) - Equity per Share|BMRN: Net Assets per Single Share|Net Assets per Share BBIO|BGM - Net Assets per Single Share|Share Book Value Cogent Corp (COGT)|XERS: Book Value per Share|Net Asset Value per Share kerostx.com KROS|ARCT: Book Value per Share|KMDA - Accounting Value per Share|Fulcrum Tx - Book Value per Share|Abeona Therapeutics Inc. (ABEO) - Net Assets per Share|MREO (Mereo BioPharma Group) - Book Value per Share|Book Value per Share PLX|Net Assets per Single Share Pliant Therapeutics (PLRX)|Net Assets per Single Share appliedtherapeutics.com (APLT)|Book Value per Share RNTX|GELS - Net Assets per Share|Accounting Value per Share Aytu Therapeutics|CMMB - Share Book Value|Book Value per Share SRXH|Polyrizon (PLRZ) - Net Asset Value per Share|Book Value per Share Aeterna Zentaris Inc (AEZS)|Equity per Share Cyclo Therapeutics, Inc (CYTH)|Inozyme Pharma, Inc. (INZY) - Accounting Value per Share|Accounting Value of a Share RPHM (reneopharma.com)|COSCIENS Biopharma (CSCI) - Net Assets per Single Share